DAX25.044 -0,9%Est506.060 -0,7%MSCI World4.343 -0,1%Top 10 Crypto8,5800 -2,4%Nas22.632 -0,5%Bitcoin56.729 +0,6%Euro1,1773 -0,1%Öl71,65 +1,9%Gold4.979 +0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 SAP 716460 Siemens Energy ENER6Y NVIDIA 918422 Airbus 938914 Deutsche Telekom 555750 Infineon 623100 Amazon 906866 Microsoft 870747 Lufthansa 823212 RENK RENK73 DroneShield A2DMAA Siemens 723610 BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich tiefrot - aber über 25.000-Punkte-Marke -- Bayer profitiert von Glyphosat-Vorstoß durch Trump -- Airbus, Apple, Amazon, DroneShield, Siemens Energy, Microsoft, Figma, eBay, SAP im Fokus
Top News
USD Coin: Hätte sich eine Kapitalanlage von vor 1 Jahr gelohnt? USD Coin: Hätte sich eine Kapitalanlage von vor 1 Jahr gelohnt?
So lukrativ wäre ein Solana-Investment von vor 5 Jahren gewesen So lukrativ wäre ein Solana-Investment von vor 5 Jahren gewesen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Amgen Aktie

Kaufen
Verkaufen
Amgen Aktien-Sparplan
318,65 EUR -2,85 EUR -0,89 %
STU
374,89 USD -4,82 USD -1,27 %
BTT
Amgen jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.170,52 Mrd. EUR

KGV23,01Div. Rendite2,91%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN867900

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS0311621009

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolAMGN

Amgen Aktien News

DatumMeistgelesen
PR NewswireUPLIZNA® (INEBILIZUMAB-CDON) IS NOW THE FIRST AND ONLY FDA-APPROVED TREATMENT FOR IGG4-RELATED DISEASE
PR NewswireUPLIZNA® (INEBILIZUMAB-CDON) SIGNIFICANTLY IMPROVES GENERALIZED MYASTHENIA GRAVIS SYMPTOMS IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY-POSITIVE PATIENTS OVER 52 WEEKS
PR NewswireAMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
PR NewswireAMGEN AND KYOWA KIRIN PROVIDE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 IGNITE STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
PR NewswireAMGEN ANNOUNCES 2025 SECOND QUARTER DIVIDEND
PR NewswirePOSITIVE RESULTS FROM TEZSPIRE® (TEZEPELUMAB-EKKO) PHASE 3 WAYPOINT TRIAL HIGHLIGHT RAPID, SUSTAINED EFFECT IN CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
PR NewswireAMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
PR NewswireAMGEN TO PRESENT AT CITI'S 2025 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
PR NewswireAMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE
PR NewswireAMGEN ANNOUNCES WEBCAST OF 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
PR NewswireEUROPÄISCHE KOMMISSION GENEHMIGT BLINCYTO® BEI PHILADELPHIA-CHROMOSOM-NEGATIVER CD19-POSITIVER B-ZELL-VORLÄUFER-AKUTER LYMPHOBLASTISCHER LEUKÄMIE IN DER KONSOLIDIERUNGSPHASE
PR NewswireEUROPEAN COMMISSION APPROVES BLINCYTO® IN PHILADELPHIA CHROMOSOME-NEGATIVE CD19-POSITIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA IN THE CONSOLIDATION PHASE
PR NewswireFDA APPROVES LUMAKRAS® (SOTORASIB) IN COMBINATION WITH VECTIBIX® (PANITUMUMAB) FOR CHEMOREFRACTORY KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
PR NewswireAMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
PR NewswireAMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDEND
PR NewswireAMGEN ANNOUNCES $1 BILLION MANUFACTURING EXPANSION IN NORTH CAROLINA
PR NewswireAMGEN TO PRESENT AT CITI'S 2024 GLOBAL HEALTHCARE CONFERENCE
PR NewswireAMGEN TO PRESENT AT THE 7th ANNUAL EVERCORE HEALTHCONx CONFERENCE
PR NewswireAMGEN ANNOUNCES ROBUST WEIGHT LOSS WITH MARITIDE IN PEOPLE LIVING WITH OBESITY OR OVERWEIGHT AT 52 WEEKS IN A PHASE 2 STUDY
PR NewswireAMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM
PR NewswireAMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
PR NewswireAMGEN PRESENTS NEW DATA ACROSS RARE INFLAMMATORY DISEASES AT ACR 2024
PR NewswireAMGEN PROVIDES STATEMENT ON MARITIDE PHASE 1 DATA
PR NewswireAMGEN TO PRESENT AT THE 2024 UBS GLOBAL HEALTHCARE CONFERENCE
PR NewswireTEZSPIRE MET BOTH CO-PRIMARY ENDPOINTS IN PHASE 3 TRIAL FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS
PR NewswireAMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND
PR NewswireAMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS
PR NewswireAMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024
PR NewswireLA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE
PR NewswireTEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE
PR NewswireAMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE
PR NewswireAMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024
PR NewswireAMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024
PR NewswireAMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
PR NewswireAMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
PR NewswireAMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND
PR NewswireAMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS
PR NewswireFDA APPROVES BLINCYTO® (BLINATUMOMAB) IN CD19-POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) IN THE CONSOLIDATION PHASE
PR NewswireAMGEN TO PRESENT INNOVATIVE RHEUMATOLOGY RESEARCH AT EULAR 2024
PR NewswireAMGEN TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

Amgen News

Amgen News: auf dieser Seite finden Sie alle Amgen News und Nachrichten zur Amgen Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Amgen News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Amgen News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.